Skip to main content
G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.990
+0.130 (3.37%)
Apr 26, 2024, 4:00 PM EDT - Market closed

G1 Therapeutics Revenue

In the year 2023, G1 Therapeutics had annual revenue of $82.51M with 60.84% growth. Revenue in the quarter ending December 31, 2023 was $14.87M with 45.10% year-over-year growth.

Revenue (ttm)
$82.51M
Revenue Growth
+60.84%
P/S Ratio
2.52
Revenue / Employee
$825,110
Employees
100
Market Cap
208.28M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202382.51M31.21M60.84%
Dec 31, 202251.30M19.83M62.98%
Dec 31, 202131.48M-13.81M-30.49%
Dec 31, 202045.29M--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 2015522.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GTHX News

More News